Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Umut DİŞEL"'
Autor:
Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kilickap
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Introduction The advances in immune checkpoint inhibitors (ICIs) were relatively slow in rare tumors. Therefore, we conducted a multi‐center study evaluating the efficacy of ICI monotherapy and the combination of ICIs with chemotherapy (CT
Externí odkaz:
https://doaj.org/article/0f697c742e7245d3a185d956a2ca5f1a
Autor:
Mustafa Gürbüz, Saadettin Kiliçkap, Ahmet Bilici, Nuri Karadurmuş, Ahmet Sezer, Mehmet Ali Nahit Şendur, Semra Paydaş, Mehmet Artaç, Perran Fulden Yumuk, Pinar Gürsoy, Mükremin Uysal, Hasan Şenol Coşkun, Ali Murat Tatli, Fatih Selçukbiricik, Umut Dişel, Elif Berna Köksoy, Deniz Can Güven, Muzaffer Uğrakli, Erman Akkuş, Şebnem Yücel, Cihan Erol, Serdar Karakaya, Teoman Şakalar, Nijat Khanmammadov, Nail Paksoy, Ahmet Demirkazik
Publikováno v:
Medicine. 101(50)
Crizotinib is a multikinase inhibitor, effective in non-small cell lung cancer (NSCLC) harboring mesenchymal-epidermal transition (MET) alterations. Although small prospective studies showed efficacy and safety of crizotinib in NSCLC with MET alterat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fa05044789f228338ef3c9ada33cec1
https://pubmed.ncbi.nlm.nih.gov/36550824
https://pubmed.ncbi.nlm.nih.gov/36550824
Autor:
Umut DİŞEL, Fatih KÖSE, Ahmet BİLİCİ, Mustafa ÖZGÜROĞLU, Sezer SAĞLAM, Mesut ŞEKER, Sercan AKSOY, İbrahim TEK, Nil Molinas MANDEL, Gökhan DEMİR, Çağatay ARSLAN, Mutlu DEMİRAY, Mehmet Akif ÖZTÜRK, Taflan SALEPÇİ, Yeşim ERALP, Fatih SELÇUKBİRİCİK, Gökçe TEMİZAŞ, Ebru Gül FİDAN
© 2022 by Turkish Society of Medical Oncology.Objective: The development of bioinformatics and comprehensive genomic profiling (CGP) has provided insights into the ap-plicability and functionality of the genomic alterations (GA). In this study, we e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac4d7eb3f22264639561fd4d8532643b
https://hdl.handle.net/20.500.12511/9715
https://hdl.handle.net/20.500.12511/9715
Autor:
Cemile Karadeniz, Huseyin Mertsoylu, Ozgur Ozyilkan, Umut Dişel, Ahmet TanerSümbül, Huseyin Abali, Fatih Kose, Özlem Gürkut, Ahmet Sezer, Ayberk Besen, Sadık Muallaoğlu
Publikováno v:
Medical Oncology. 29:3608-3613
The relationship between thyroid disease and cancer (and cancer therapies) has been under investigation for years. Factors that increase the risk for thyroid disease include iodine deficiency, autoimmune disorders, old age, and pregnancy. The screeni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a84c33f4560173e8db141d7424b4aed
https://doi.org/10.1007/s12032-012-0254-4
https://doi.org/10.1007/s12032-012-0254-4
Autor:
Ahmet Taner Sümbül, Ali Ayberk Besen, Fatih Kose, Umut Dişel, Ozgur Ozyilkan, Sadık Muallaoğlu, Ahmet Sezer, Huseyin Abali, Levent Oguzkurt, Kamil Gurel, Ugur Ozkan
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 21(4)
Patients with advanced cancer may present with obstructive jaundice. Biliary stenting is the treatment of choice. However, which patients benefit most is not well-defined, yet. Our aim was to delineate the clinical factors affecting prognosis. Charts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35478684808c0e14dbb189ba4a41ab86
https://pubmed.ncbi.nlm.nih.gov/23132146
https://pubmed.ncbi.nlm.nih.gov/23132146
Publikováno v:
Leukemialymphoma. 53(9)
Chronic myeloid leukemia (CML) is a clonal stem cell disorder, and imatinib is a small molecule inhibitor of Bcr–Abl tyrosine kinase (TK) used in cases with CML. Immediate and short-term side effects of this tyrosine kinase inhibitor (TKI) are well
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::220210cf6b0a00abf694ae3a212ca772
https://pubmed.ncbi.nlm.nih.gov/22360717
https://pubmed.ncbi.nlm.nih.gov/22360717
Publikováno v:
J Clin Hypertens (Greenwich)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfe1014b4a7e2534246d5ca39ad5072a
https://pubmed.ncbi.nlm.nih.gov/22051434
https://pubmed.ncbi.nlm.nih.gov/22051434
Autor:
Umut Dişel, Ozgur Ozyilkan, Ayberk Besen, Ahmet Sezer, Taner Sumbul, Cemile Karadeniz, Fatih Kose, Levent Oguzkurt, Huseyin Mertsoylu
Publikováno v:
European journal of radiology. 81(8)
Purpose: Patients with advanced cholangiocarcinoma present with high rate of local complications. The primary aim of this study is to report clinical course of advanced cholangiocarcinoma patients those who were presented with biliary obstruction and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d12722b5edc2a8e2217cd6f856f8e8df
https://pubmed.ncbi.nlm.nih.gov/21596502
https://pubmed.ncbi.nlm.nih.gov/21596502
Autor:
Fatih Kose, Cemile Karadeniz, Ali Ayberk Besen, Serdar Oztuzcu, Gül Nihal Nursal, Ahmet Taner Sümbül, Umut Dişel, Ahmet Sezer, Huseyin Abali, Ozgur Ozyilkan
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 71(1)
Advanced thymic carcinoma (TC) is a very aggressive disease. To date there are no established treatment options for the refractory and recurrent disease and only a few prospective trials have been conducted in patients with TC. Here we present a case
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::496ab33617b9fec2ea995f15eec1b9de
https://pubmed.ncbi.nlm.nih.gov/20970876
https://pubmed.ncbi.nlm.nih.gov/20970876
Autor:
Huseyin Mertsoylu, Muhammad Wasif Saif, Umut Dişel, Özlem Gürkut, Ozgur Ozyilkan, Huseyin Abali, Hakan Kaleagasi
Publikováno v:
Cutaneous and ocular toxicology. 29(2)
Hand-foot syndrome (HFS), the most common toxicity of capecitabine, is characterized by tingling, numbness, pain, erythema, dryness, rash, swelling, increased pigmentation, and/or pruritus of the palmar and/or plantar surfaces of the hands and/or fee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f32512fec7df66a6911a823b61254639
https://pubmed.ncbi.nlm.nih.gov/20298142
https://pubmed.ncbi.nlm.nih.gov/20298142